# Integra LifeSciences

Type: Company (IART)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/integra-lifesciences
Canonical HTML page: https://gethealthbrief.com/entity/integra-lifesciences

## Recent coverage (1 stories)

### Integra LifeSciences Shares Sink as Operational Headwinds Offset Acclarent Gains
2026-02-26 22:44:27 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Integra LifeSciences reported Q4 2025 results that failed to meet investor expectations, driven by persistent manufacturing challenges and a slower-than-anticipated recovery in its Tissue Technologies segment. Despite growth in the newly acquired Acclarent business, the company's conservative 2026 guidance has triggered a significant market sell-off.
Full story: https://gethealthbrief.com/story/integra-lifesciences-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.